Next Article in Journal
Camelid Single-Domain Antibodies (VHHs) against Crotoxin: A Basis for Developing Modular Building Blocks for the Enhancement of Treatment or Diagnosis of Crotalic Envenoming
Next Article in Special Issue
Paralytic Shellfish Toxins Occurrence in Non-Traditional Invertebrate Vectors from North Atlantic Waters (Azores, Madeira, and Morocco)
Previous Article in Journal
“Appropriate Treatment” and Therapeutic Window in Spasticity Treatment with IncobotulinumtoxinA: From 100 to 1000 Units
Previous Article in Special Issue
Fatal Canine Intoxications Linked to the Presence of Saxitoxins in Stranded Marine Organisms Following Winter Storm Activity
Article Menu
Issue 4 (April) cover image

Export Article

Open AccessArticle
Toxins 2018, 10(4), 141;

Dose-Response Modelling of Paralytic Shellfish Poisoning (PSP) in Humans

Risk Assessment Department, ANSES (French Agency for Food, Environmental and Occupational Health & Safety), 94701 Maisons-Alfort, France
Authors to whom correspondence should be addressed.
Received: 7 March 2018 / Revised: 24 March 2018 / Accepted: 27 March 2018 / Published: 28 March 2018
(This article belongs to the Special Issue Paralytic Shellfish Toxins)
Full-Text   |   PDF [10863 KB, uploaded 3 May 2018]   |  


Paralytic shellfish poisoning (PSP) is caused by a group of marine toxins with saxitoxin (STX) as the reference compound. Symptoms in humans after consumption of contaminated shellfish vary from slight neurological and gastrointestinal effects to fatal respiratory paralysis. A systematic review was conducted to identify reported cases of human poisoning associated with the ingestion of shellfish contaminated with paralytic shellfish toxins (PSTs). Raw data were collected from 143 exposed individuals (113 with symptoms, 30 without symptoms) from 13 studies. Exposure estimates were based on mouse bioassays except in one study. A significant relationship between exposure to PSTs and severity of symptoms was established by ordinal modelling. The critical minimal dose with a probability higher than 10% of showing symptoms is 0.37 µg STX eq./kg b.w. This means that 10% of the individuals exposed to this dose would have symptoms (without considering the severity of the symptoms). This dose is four-fold lower than the lowest-observed-adverse-effect-level (LOAEL) established by the European Food Safety Authority (EFSA, 2009) in the region of 1.5 μg STX eq./kg b.w. This work provides critical doses that could be used as point of departure to update the acute reference dose for STX. This is the first time a dose-symptoms model could be built for marine toxins using epidemiological data. View Full-Text
Keywords: marine biotoxins; PSP; saxitoxin; STX; dose-response; ordinal modelling marine biotoxins; PSP; saxitoxin; STX; dose-response; ordinal modelling

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Arnich, N.; Thébault, A. Dose-Response Modelling of Paralytic Shellfish Poisoning (PSP) in Humans. Toxins 2018, 10, 141.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Toxins EISSN 2072-6651 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top